Skip to main content
padlock icon - secure page this page is secure

Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy

Buy Article:

$52.00 + tax (Refund Policy)

Background: Thyroid carcinoma in children is rare and raises unique management issues. Although metastatic disease is more common in this age group, prognosis remains good with appropriate treatment. The aim of the study was to report recent experience in the management of differentiated thyroid carcinoma in children, especially in the use of radioiodine after recombinant human thyroid stimulating hormone (rhTSH) stimulation.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: paediatric; radiation; radioiodine; recombinant human thyroid stimulating hormone; thyroid cancer

Document Type: Research Article

Affiliations: Royal Children’s Hospital, Melbourne, Victoria, Australia

Publication date: September 1, 2006

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more